PHV-wordings
Here you will find safety-relevant information that must be implemented in the corresponding product information due to a PHV issues.
Due to the relaunch of the EMA website in December 2023, you will find the current links to the entries prior to December 01, 2023 at https://www.ema.europa.eu
Core Safety Profile Fosfomycin (i.v.)
PSUR-outcome
|
23/04/2015
Core Safety Profile Fosfomycin (oral)
PSUR-outcome
|
23/04/2015
Hydroxyzin
Referral
|
13/04/2015
Risiko für Effekte auf den Herzrhythmus.
Nähere Informationen finden Sie auf der Website der EMA.
Diclofenac ophth. (EU PSUR Worksharing Summary Assessment Report)
PSUR-outcome
|
30/03/2015
Desogestrel (EU PSUR Worksharing Summary Assessment Report)
PSUR-outcome
|
30/03/2015
Paracetamol Infusionslösung (EU PSUR Worksharing Summary Assessment Report)
PSUR-outcome
|
25/03/2015
Core Safety Profile Iohexol
PSUR-outcome
|
25/03/2015
Core Safety Profile Iodixanol
PSUR-outcome
|
25/03/2015
Finasterid 5mg (EU PSUR Worksharing Summary Assessment Report)
PSUR-outcome
|
25/03/2015
Iloprost (EU PSUR Worksharing Summary Assessment Report)
PSUR-outcome
|
25/03/2015
